ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1951

The Incidence Rate of Giant Cell Arteritis in Slovenia

Natasa Potocnik1, Alojzija Hocevar1, Ziga Rotar1, Joze Pizem2, Marko Hawlina3, Ana Fakin3 and Matija Tomšič1, 1Department of Rheumatology, University Medical Centre Ljubljana, Ljubljana, Slovenia, 2Institute of Pathology, University of Ljubljana, Faculty of Medicine, Ljubljana, Slovenia, 3Department of Ophthalmology, University Medical Centre Ljubljana, Ljubljana, Slovenia

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: giant cell arteritis and vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Vasculitis Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Giant cell arteritis (GCA) is the most common systemic vasculitis in adults aged 50 years or above. Annual incidence rates vary widely from 6.9–76.6 per 105 of adults in this age group, depending on the region.1 Our aim was to determine the incidence rate of GCA in our population.

Methods: We prospectively collected incident cases of GCA from January 1st 2011 to December 31st 2014 at our department of rheumatology which is a part of an integrated secondary/tertiary university teaching hospital that is the only referral center serving a region representing approximately a quarter of the national adult population. Additionally, newly diagnosed cases of GCA between January 1st 2009 and December 31st 2010 were retrospectively identified by searching the electronic patient records for ICD-10 codes M31.5 and M31.6 at our department. The retrospective approach and search strategy was also applied on electronic medical records at the departments of infectious diseases and ophthalmology between January 1st 2009 and December 31st 2014. To further reduce possibility of underreporting, the attached medical faculty’s Institute of Pathology provided a list of all temporal artery biopsies examined during the observation period which were then cross-referenced with the hospital’s electronic medical records. Annual incidence rate for GCA was then calculated.

Results:

During the six year observation period we identified 137 new cases of GCA (68% female; mean (IQR) age 75.9 (11.1) years) from a well-defined adult white Caucasian population of 235,596 inhabitants aged 50 or above. The temporal artery biopsy was consistent with GCA, negative or not performed in 80.2 %, 19.8 %, and 8.0 % of cases, respectively. Thus, the average six years annual incidence of GCA in our population is 9.7 (95 % CI 8.1–15.5), the highest was in 2010 (11.7 (95% CI 7.7-17.1)), and the lowest in 2013 (7.5 (95% CI 4.4-11.8)) per 105 adults aged 50 or above.

Conclusion:

The average annual incidence rate of 9.7 per 105 adults aged 50 or above makes GCA the most common systemic vasculitis in our population. 

Reference:

1. Gonzalez-Gay MA, Vazquez-Rodriguez TR, Lopez-Diaz MJ et al. Epidemiology of Giant Cell Arteritis and Polymyalgia Rheumatica. Arthritis Rheum 2009;61:1454-61.


Disclosure: N. Potocnik, None; A. Hocevar, None; Z. Rotar, None; J. Pizem, None; M. Hawlina, None; A. Fakin, None; M. Tomšič, None.

To cite this abstract in AMA style:

Potocnik N, Hocevar A, Rotar Z, Pizem J, Hawlina M, Fakin A, Tomšič M. The Incidence Rate of Giant Cell Arteritis in Slovenia [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/the-incidence-rate-of-giant-cell-arteritis-in-slovenia/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-incidence-rate-of-giant-cell-arteritis-in-slovenia/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology